FOXO TECHNOLOGIES INC. Payments of Stock Issuance Costs
FOXO TECHNOLOGIES INC. (FOXO) reported Payments of Stock Issuance Costs of $1.34 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-06-28
- FOXO TECHNOLOGIES INC. payments of stock issuance costs for the quarter ending 2024-03-31 was $1.34M.
- FOXO TECHNOLOGIES INC. payments of stock issuance costs for the quarter ending 2023-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. payments of stock issuance costs for the quarter ending 2023-09-30 was $0.00.
- FOXO TECHNOLOGIES INC. payments of stock issuance costs for fiscal 2023 was $1.34M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 8 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $1.34M 10-Q · filed 2024-06-28 | $1.34M derived: sum of 2 quarters · filed 2024-06-28 | $1.34M derived: sum of 3 quarters · filed 2024-06-28 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $1.34M 10-K · filed 2024-06-06 | ||
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-06-04 | $1.34M 10-Q/A · filed 2024-06-04 | |||
| 2023-06-30 | $1.34M 10-Q · filed 2023-08-10 | ||||
| 2020-12-31 | $259.90K 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |